MEC Plus Full List View

MEC Plus

Targeted Therapy in NSCLC
Targeted Therapy in NSCLC
Bruna Pellini, MD
Immunotherapy in NSCLC: Advanced Disease and Resistance
Immunotherapy in NSCLC: Advanced Disease and Resistance
George Simon, MD
Prostate Cancer: What is the Best Combination Therapy?
Prostate Cancer: What is the Best Combination Therapy?
Chandler H. Park, MD
Gynecologic Malignancies: New Therapeutic Developments
Gynecologic Malignancies: New Therapeutic Developments
Alexander B. Olawaiye, MD
Updates in Kidney and Bladder Cancers: Immunotherapy and Targeted Therapy
Updates in Kidney and Bladder Cancers: Immunotherapy and Targeted Therapy
Pedro Barata, MD
Latest Advances in Gastrointestinal Cancers
Latest Advances in Gastrointestinal Cancers
Edward Kim, MD, PhD
Therapeutic Advances in Gynecologic Oncology
Therapeutic Advances in Gynecologic Oncology
Rebecca Brooks, MD
New Therapeutic Directions in Lung Cancer
New Therapeutic Directions in Lung Cancer
Surbhi Singhal, MD
State of the Art in Genitourinary Cancers
State of the Art in Genitourinary Cancers
Nicholas Mitsiades, MD, PhD
Recent Advances in Breast Cancer
Recent Advances in Breast Cancer
Mili Arora, MD
ALL REVOLUTION: Improving Outcomes for ALL
ALL REVOLUTION: Improving Outcomes for ALL
Wendy Stock, MD
HER2 Targeted Therapies: Recent Advances
HER2 Targeted Therapies: Recent Advances
Helen Chew, MD, FACP
New Biomarkers in Breast Cancer
New Biomarkers in Breast Cancer
Joanne Mortimer, MD, FACP, FASCO
Hormone Therapy in Breast Cancer: New Directions
Hormone Therapy in Breast Cancer: New Directions
Mili Arora, MD
Targeting the Microbiome and Optimizing Immunotherapy in Cancer
Targeting the Microbiome and Optimizing Immunotherapy in Cancer
Sumanta K. Pal, MD, FASCO
Targeting RAS-RAF-MAPK Pathway
Targeting RAS-RAF-MAPK Pathway
Jacob Thomas, MD
Hippo-Yap Pathway
Hippo-Yap Pathway
Janai Carr-Ascher, MD, PhD
Novel Targets in Hematologic Malignancies
Novel Targets in Hematologic Malignancies
Tycel Phillips, MD
Lymphoma: State of the Art
Lymphoma: State of the Art
Alexey Danilov, MD, PhD
AML and MDS: New Directions
AML and MDS: New Directions
Olatoyosi Odenike, MD
Systemic Therapy in Urothelial Carcinoma
Systemic Therapy in Urothelial Carcinoma
Sarmad Sadeghi, MD, PhD
Management of Renal Cell Carcinoma
Management of Renal Cell Carcinoma
Shuchi Gulati, MD, MS, FACP
Castration Resistant Prostate Cancer: What is the Optimal Strategy?
Castration Resistant Prostate Cancer: What is the Optimal Strategy?
Mamta Parikh, MD, MS
State of the Art: Hormone-sensitive Prostate Cancer
State of the Art: Hormone-sensitive Prostate Cancer
Abhishek Tripathi, MD
Precision Oncology and Landmark Advances in GU Malignancies
Precision Oncology and Landmark Advances in GU Malignancies
Walter M. Stadler, MD, FACP
Updates in Locally Advanced Unresectable (Stage III) NSCLC
Updates in Locally Advanced Unresectable (Stage III) NSCLC
Jorge Nieva, MD
Advances in Limited and Extensive Stage Small Cell Lung Cancer
Advances in Limited and Extensive Stage Small Cell Lung Cancer
Jyoti Malhotra, MD, MPH
Updates in NSCLC Targeted Therapy
Updates in NSCLC Targeted Therapy
Jonathan W. Riess, MD, MS
Updates in Immunotherapy for Metastatic Lung Cancer
Updates in Immunotherapy for Metastatic Lung Cancer
Erminia Massarelli, MD, PhD, MS